Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs

BACKGROUND: The study examined the prevalence of early treatment revisions after glycosylated hemoglobin (HbA1c) ≥9.0% (75 mmol/mol) and estimated the impact of early treatment revisions on glycemic control, diabetic complications, and costs. RESEARCH DESIGN AND METHODS: A retrospective cohort study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open Diabetes Res Care
Autors principals: Schwab, Phil, Saundankar, Vishal, Bouchard, Jonathan, Wintfeld, Neil, Suehs, Brandon, Moretz, Chad, Allen, Elsie, DeLuzio, Antonio
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2016
Matèries:
Epidemiology/Health Services Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4761990/
https://ncbi.nlm.nih.gov/pubmed/26925237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2015-000099
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars